pharmacopeia

Mechanism of action

Sourced from openFDA

Mechanism-of-action classes: 14-alpha Demethylase Inhibitors; Ergosterol Synthesis Inhibitors.

14-alpha DemethylaseErgosterol Synthesis

Indications

Sourced from openFDA
  • GYNAZOLE • 1 ® Butoconazole Nitrate Vaginal Cream USP, 2% is indicated for the local treatment of vulvovaginal candidiasis (infections caused by Candida ). The diagnosis should be confirmed by KOH smears and/or cultures (see CLINICAL STUDIES ).ICD-10: B37.9

Contraindications

Sourced from openFDA
  • GYNAZOLE • 1 ® Butoconazole Nitrate Vaginal Cream USP, 2% is contraindicated in patients with a history of hypersensitivity to any of the components of the product.contraindicated

Dosage & administration

Sourced from openFDA

The recommended dose of GYNAZOLE • 1 ® Butoconazole Nitrate Vaginal Cream USP, 2% is one applicatorful of cream (approximately 5 grams of the cream) intravaginally. This amount of cream contains approximately 100 mg of butoconazole nitrate.

Warnings & precautions

Sourced from openFDA

This cream contains mineral oil. Mineral oil may weaken latex or rubber products such as condoms or vaginal contraceptive diaphragms; therefore, use of such products within 72 hours following treatment with GYNAZOLE•1 ® Butoconazole Nitrate Vaginal Cream USP, 2% is not recommended. Recurrent vaginal yeast infections, especially those that are difficult to eradicate, can be an early sign of infection with the human immunodeficiency virus (HIV) in women who are considered at risk for HIV infection.

Adverse reactions

Sourced from openFDA

Of the 314 patients treated with GYNAZOLE • 1 ® Butoconazole Nitrate Vaginal Cream USP, 2% for 1 day in controlled clinical trials, 18 patients (5.7%) reported complaints such as vulvar/vaginal burning, itching, soreness and swelling, pelvic or abdominal pain or cramping, or a combination of two or more of these symptoms. In 3 patients (1%) these complaints were considered treatment-related. Five of the 18 patients reporting adverse events discontinued the study because of them.

Use in specific populations

Sourced from openFDA

Pregnancy:

Approval history

Sourced from openFDA
  • May 18, 2012ANDAANDA200923Padagis Israel

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
5 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Anxiety240%
  2. 2Depression240%
  3. 3Exposure During Pregnancy240%
  4. 4Abdominal Pain120%
  5. 5Attention Deficit/hyperactivity Disorder120%
  6. 6Cerebrovascular Disorder120%
  7. 7Congenital Flat Feet120%
  8. 8Convulsion120%
  9. 9Deep Vein Thrombosis120%
  10. 10Developmental Delay120%
  11. 11Developmental Hip Dysplasia120%
  12. 12Flatulence120%
  13. 13Fungal Infection120%
  14. 14Hyperkinesia120%
  15. 15Joint Contracture120%

Clinical trials

View JSON

The 4 most recently updated of 4 ClinicalTrials.gov registrations naming Butoconazole as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Butoconazole work?
Mechanism-of-action classes: 14-alpha Demethylase Inhibitors; Ergosterol Synthesis Inhibitors.
What is Butoconazole used for?
According to FDA labeling, Butoconazole carries indications including: GYNAZOLE • 1 ® Butoconazole Nitrate Vaginal Cream USP, 2% is indicated for the local treatment of vulvovaginal candidiasis (infections caused by Candida ). The diagnosis should be confirmed by KOH smears and/or cultures (see CLINICAL STUDIES ).. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Butoconazole?
Butoconazole is classified as Imidazole derivatives, Azole Antifungal, 14-alpha Demethylase Inhibitors, Ergosterol Synthesis Inhibitors, Decreased Cell Membrane Integrity.
What are the brand names for Butoconazole?
Butoconazole is marketed under brand names including Gynazole-1.
What are the contraindications for Butoconazole?
Butoconazole labeling lists contraindications including: GYNAZOLE • 1 ® Butoconazole Nitrate Vaginal Cream USP, 2% is contraindicated in patients with a history of hypersensitivity to any of the components of the product.. Always consult the full prescribing information and a clinician.
Note. Data for butoconazole is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients